Orano Med
Nicolas Bozovic has a diverse work experience in various roles and industries. Starting in 2006, they worked as an Intern at The Boston Consulting Group. In 2007, they became a Consultant at the same company and continued in that role until 2010. In 2011, they joined AlixPartners as an Associate for a short period of time before moving to AREVA as a Strategy Manager. From 2014 to 2019, Nicolas worked at AREVA Med (now Orano Med) as the Director of Development, where they were responsible for negotiating partnerships, managing innovation projects, and developing strategic plans. Since 2020, Nicolas has held the position of Distribution and Logistics Director at Orano Med, overseeing the development of the company's supply chain for radiopharmaceuticals. Currently, they hold the position of Director of Pharmaceutical Operations and Projects at Orano Med.
Nicolas Bozovic attended CentraleSupélec from 2003 to 2006. During this time, they pursued the Option Génie Industriel and focused on the field of study in Stratégie-Marketing-Finances.
This person is not in any offices
Orano Med
1 followers
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.